Heron Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
ALKERMES USD 399.81M 108.66M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 119.52M 1.51M 2025-03
ANI Pharmaceuticals USD 149.8M 4.94M 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
Eisai JPY 265.56B 25.7B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Insmed USD 403.25M 151.78M 2025-03
Ligand Pharmaceuticals USD 256.89M 184.58M 2025-03
Merck USD 8.63B 4.61B 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Pacira USD 283.61M 6.84M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Veracyte USD 186.12M 52.97M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Heron Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.